CDK7 inhibition suppresses MYC-dependent cancer

被引：0
|
作者：
Sarah Crunkhorn
机构：
来源：
Nature Reviews Drug Discovery | 2015年 / 14卷 / 1期
关键词：
D O I：
10.1038/nrd4513
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：16 / 16
相关论文
共 50 条
  • [41] TARGETING TRANSCRIPTIONAL ADDICTION FOR GBM THERAPY THROUGH CDK7 INHIBITION
    Meng, Wei
    Wang, Jiajia
    Li, Qifeng
    Liu, Fang
    Li, Meng
    Jiang, Wenyan
    Lin, Li
    Dai, Xiaomin
    Wang, Hongxiang
    Zhang, Chenran
    Wang, Baocheng
    Chen, Juxiang
    Zhang, Liye
    Tang, Yujie
    Ma, Jie
    NEURO-ONCOLOGY, 2018, 20 : 180 - 180
  • [42] Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells
    Jian Kang
    C Marcelo Sergio
    Robert L Sutherland
    Elizabeth A Musgrove
    BMC Cancer, 14
  • [43] Linking cancer transcriptional addictions by CDK7 to YAP/TAZ
    Piccolo, Stefano
    GENES & DEVELOPMENT, 2020, 34 (1-2) : 4 - 6
  • [44] Targeting transcription regulation in cancer with a covalent CDK7 inhibitor
    Kwiatkowski, Nicholas
    Zhang, Tinghu
    Rahl, Peter B.
    Abraham, Brian J.
    Reddy, Jessica
    Ficarro, Scott B.
    Dastur, Anahita
    Amzallag, Arnaud
    Ramaswamy, Sridhar
    Tesar, Bethany
    Jenkins, Catherine E.
    Hannett, Nancy M.
    McMillin, Douglas
    Sanda, Takaomi
    Sim, Taebo
    Kim, Nam Doo
    Look, Thomas
    Mitsiades, Constantine S.
    Weng, Andrew P.
    Brown, Jennifer R.
    Benes, Cyril H.
    Marto, Jarrod A.
    Young, Richard A.
    Gray, Nathanael S.
    NATURE, 2014, 511 (7511) : 616 - +
  • [45] Targeting transcription regulation in cancer with a covalent CDK7 inhibitor
    Nicholas Kwiatkowski
    Tinghu Zhang
    Peter B. Rahl
    Brian J. Abraham
    Jessica Reddy
    Scott B. Ficarro
    Anahita Dastur
    Arnaud Amzallag
    Sridhar Ramaswamy
    Bethany Tesar
    Catherine E. Jenkins
    Nancy M. Hannett
    Douglas McMillin
    Takaomi Sanda
    Taebo Sim
    Nam Doo Kim
    Thomas Look
    Constantine S. Mitsiades
    Andrew P. Weng
    Jennifer R. Brown
    Cyril H. Benes
    Jarrod A. Marto
    Richard A. Young
    Nathanael S. Gray
    Nature, 2014, 511 : 616 - 620
  • [46] Ras/MEK signaling suppresses Myc-dependent apoptosis in cells transformed by c-myc and activated ras
    Tsuneoka, M
    Mekada, E
    ONCOGENE, 2000, 19 (01) : 115 - 123
  • [47] CDK7 in breast cancer: mechanisms of action and therapeutic potential
    Gong, Ying
    Li, Huiping
    CELL COMMUNICATION AND SIGNALING, 2024, 22 (01)
  • [48] The Mediator captures CDK7, an attractive transcriptional target in cancer
    Wang, Yubao
    Manokaran, Cherubin
    Wu, Su
    Roberts, Thomas M.
    CANCER CELL, 2021, 39 (09) : 1184 - 1186
  • [49] CDK7 Inhibitors in Cancer Therapy: The Sweet Smell of Success?
    Diab, Sarah
    Yu, Mingfeng
    Wang, Shudong
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (14) : 7458 - 7474
  • [50] Inhibition of CDK7 overcomes resistance to CDK4/6 inhibitors in hormone receptor positive breast cancer cells
    Guarducci, C.
    Nardone, A.
    Feiglin, A.
    Migliaccio, I.
    Malorni, L.
    Bonechi, M.
    Benelli, M.
    Di Leo, A.
    Hodgson, G.
    Shapiro, G.
    Brown, M.
    Jeselsohn, R.
    CANCER RESEARCH, 2019, 79 (04)
12345